Nozeopen 0.1% Nasal Solution
By Nozeopen
10ml Nasal Solution in a Bottle

Composition
Xylometazoline(0.1% w/v)

Manufacturer - Windlas Biotech Ltd
705-706, Vatika Professional Point, Sector-66 Golf Course Extension Road, Gurgaon - 122 001 Haryana, India

Expires on or after
August, 2026

liver
Safety Advice - Liver No interactions have been found or established with the use of Nozeopen 0.1% Nasal Solution that could potentially affect the liver. It is important to remember that every individual may react differently to medications, so if you have any concerns about the impact of Nozeopen 0.1% Nasal Solution on your liver, it is recommended to consult with your healthcare provider for personalized guidance.

kidney
No interaction or effects on the kidneys have been found or established with Nozeopen 0.1% Nasal Solution.

alcohol
No interaction has been found or established between alcohol and Nozeopen 0.1% Nasal Solution. It is always advisable to consult your doctor regarding alcohol consumption when using Nozeopen 0.1% Nasal Solution, especially during pregnancy.

driving
There is no known interaction or caution related to driving when using Nozeopen 0.1% Nasal Solution. It is considered safe for driving.

pregnancy
Nozeopen 0.1% Nasal Solution may not be safe during pregnancy, as animal studies indicate potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using this product.

breastfeeding
Nozeopen 0.1% Nasal Solution is likely safe for breastfeeding as per limited human data, indicating no significant risk to the baby.
| Habit Forming | No |
| Chemical Class | Phenylpropane Derivative |
| Therapeutic Class | - |
| Action Class | Sympthatomimmetics- alpha 1 (Nasal) |
₹55
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
